The method previously described [1] was used for testing RT inhibition. Tannin-free compounds, final concentration 200 g/mL in 10% DMSO, were added to the reaction mixture prior to the addition of HIV-1 RT (Amersham). A control assay was performed without the compounds or extracts but with an equivalent volume of 10% DMSO. Nevirapine (2 g/mL) and/or fagaronine chloride (10 g/mL, circa 50% inhibition) was used as positive control. The results from duplicate wells were averaged, and the percentage of RT inhibition was calculated. The compound that exhibited potent anti-HIV-1 RT activity was further tested
for the 50% inhibitory concentration (IC 50 ); the value was estimated from doseresponse data obtained from five serial twofold dilutions at a starting concentration of 200 g/mL.
Cell-based assay for anti-HIV-1
A combination of syncytium and colorimetric cytotoxicity assays employing a Δtat/Rev defective HIV-1 ( Δtat/Rev MC99) and 1A2 cell system was used [2, 3] . Cells in the amount of 5  10 4 cells/well, in RPMI-1640 medium supplemented with 10% inactivated fetal bovine serum, were seeded into a 96-well tissue culture plate, followed by serial twofold dilutions of the compound at a starting concentration of 125 g/mL, and incubated for an hour before the addition of virus (100150 syncytium-forming units/well). 3′-Azido-5′ thymidine (AZT) was used as a positive control of HIV-1 inhibition. Virus control wells contained cells and the virus only, cell control wells contained neither extract nor virus, and cytotoxicity control wells contained cells with the compound. The assay was carried out in triplicate wells and results were averaged. Anti-HIV-1 was expressed as the effective concentration of compound that inhibited syncytium formation by 50% (EC 50 ).
The same batch of 1A2 cells was used for the colorimetric cytotoxicity assay that was carried out in parallel. The procedure was similar to the syncytium assay, but the virus was replaced by medium and tested in duplicate wells. Control wells included medium, drug, and cell control. After incubation for three days, XTT tetrazolium-phenazine methosulfate solution was added to each well. After development of the soluble formazan, the optical density at A 450 was measured with a reference at A 650 , and the percentage of cells that were metabolically active was calculated as follows: [(OD test  OD drug control ) / (OD cell control  OD medium control )]  100. The result was expressed as the 50% inhibitory concentration (IC 50 ).
Calculation of 50% endpoint
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